Actinium Pharmaceuticals, Inc. (ATNM)
Actinium Pharmaceuticals Market Cap : 33.01M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 33.01M |
| November 19, 2026 | 33.64M |
| November 18, 2026 | 33.96M |
| November 17, 2026 | 42.45M |
| November 16, 2026 | 46.85M |
| November 13, 2026 | 51.56M |
| November 12, 2026 | 49.99M |
| November 11, 2026 | 49.99M |
| November 10, 2026 | 49.36M |
| November 09, 2026 | 48.42M |
| November 06, 2026 | 44.96M |
| November 05, 2026 | 40.87M |
| November 04, 2026 | 44.33M |
| November 03, 2026 | 44.02M |
| November 02, 2026 | 44.96M |
| October 30, 2026 | 46.53M |
| October 29, 2026 | 48.11M |
| October 28, 2026 | 43.39M |
| October 27, 2026 | 44.65M |
| October 26, 2026 | 44.02M |
| October 23, 2026 | 47.79M |
| October 22, 2026 | 50.31M |
| October 21, 2026 | 43.39M |
| October 20, 2026 | 44.02M |
| October 19, 2026 | 41.50M |
| Date | Value |
|---|---|
| October 16, 2026 | 35.53M |
| October 15, 2026 | 33.33M |
| October 14, 2026 | 30.64M |
| October 13, 2026 | 31.43M |
| October 12, 2026 | 33.33M |
| October 09, 2026 | 34.59M |
| October 08, 2026 | 33.96M |
| October 07, 2026 | 33.64M |
| October 06, 2026 | 34.90M |
| October 05, 2026 | 37.73M |
| October 02, 2026 | 36.79M |
| October 01, 2026 | 36.16M |
| September 30, 2026 | 35.21M |
| September 29, 2026 | 35.84M |
| September 28, 2026 | 37.10M |
| September 25, 2026 | 37.73M |
| September 24, 2026 | 37.42M |
| September 23, 2026 | 37.10M |
| September 22, 2026 | 36.79M |
| September 21, 2026 | 37.73M |
| September 18, 2026 | 38.36M |
| September 17, 2026 | 37.42M |
| September 16, 2026 | 38.99M |
| September 15, 2026 | 39.30M |
| September 14, 2026 | 40.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| PE Ratio | 3.131 |
| PS Ratio | 0.9396 |
| Price to Book Value | 1.343 |
| Price | 1.05 |
| Earnings Yield | 31.94% |
| Operating PE Ratio | 3.604 |
| Normalized PE Ratio | 3.131 |